Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261248 · ClinicalTrials.gov registry record · Phase 2
Vaccine for Recurrent Urinary Tract Infections in Women
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT00261248 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 75 participants.
The verdict
NCT00261248, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is determine whether a vaginal mucosal vaccine given to women with a history of recurrent urinary tract infections can reduce the number of infections occurring in a six-month study period, as compared to placebo treatment.
Interventions
- BIOLOGICAL Immunization with inactivated bacteria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 1996-11 |
| Est. Completion | 2003-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00261248
The ClinicalTrials.gov registry entry for NCT00261248 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immunization with inactivated bacteria is the first listed.
NCT00261248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00261248 about?
NCT00261248 is a clinical study titled "Vaccine for Recurrent Urinary Tract Infections in Women". The purpose of this study is determine whether a vaginal mucosal vaccine given to women with a history of recurrent urinary tract infections can reduce the number of infections occurring in a six-month study period, as compared to placebo treatment.
What is the current status of trial NCT00261248?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 1996-11. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00261248?
The interventions under investigation include: Immunization with inactivated bacteria (BIOLOGICAL).
Who is sponsoring clinical trial NCT00261248?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.